Genomics plc

At Genomics, we are the industry leader in identifying an individual's absolute risk of disease. Our platform is powered by one of the largest and most unique databases in the world, enabling everyone – from patients and healthcare providers, to insurers and employers, to pharma companies and researchers – to make smarter decisions for longer, healthier lives.

Founded in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean, our company aims to transform health through the power of genomics. We use large-scale genetic information to realise preventative medicine and improve drug discovery. Our platform provides employees with personalized tools and guidance to put them on a healthier trajectory and increase their quality of life, contributing significantly to reducing the costs associated with common diseases.